{'fraction_non_alphanumeric': 0.018162393162393164, 'fraction_numerical': 0.0, 'mean_word_length': 5.124183006535947, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Role of MicroRNAs in Breast Cancer.

Breast cancer is the most common form of cancer in women. Despite extensive study, the etiology of breast cancer remains ambiguous. A group of genetic modifiers known as microRNAs (miRNAs) are emerging onto the scene of breast cancer research. MicroRNAs are small, non-coding RNAs that are involved in the regulation of key cellular processes such as proliferation, differentiation, and apoptosis. They can interfere directly with the translation and stability of a targeted gene transcript and cause a disturbance in the cell physiology. The dysregulation of both oncogenes and tumor suppressor genes by aberrant miRNA production can result in the progression to breast cancer. This review provides a discussion of the nature of miRNAs, explains the role of miRNAs in the etiology and progression of breast cancer, and discusses their potentials as therapeutic molecules and diagnostic markers.